all report title image

PERFUSION SYSTEM MARKET ANALYSIS

Perfusion System Market, by Product Type (Cardiopulmonary Perfusion Systems, Ex Vivo Organ Perfusion Systems, and Cell Perfusion Systems), by Component (Heart-Lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas, and Others), by End User (Hospitals, Ambulatory Care Centers, and Others), and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI1661
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Challenges And Opportunities

Perfusion System Market Drivers

Increasing number of approvals and launches of new perfusion systems is expected to be major factor influencing growth of the perfusion system market in near future. For instance, in 2014, U.S. Food and Drugs Administration approved Xvivo Perfusion AB’s Xvivo Perfusion System (XPS) with STEEN solution, used in preserving initially unacceptable donor lungs while they are being evaluated as potentially viable transplantable organs. In February 2018, Paragonix Technologies, Inc. received approval for its new Paragonix SherpaPak Cardiac Transport System and SherpaPerfusion Cardiac Transport System in Europe. The SherpaPak Cardiac Transport System is used for the hypothermic static preservation and transport of donor hearts, and the SherpaPerfusion Cardiac Transport System consists of a single-use, disposable device for hypothermic oxygenated perfusion preservation and transport of donor hearts. The increasing investment by major key players in the market is also expected to fuel growth of the global perfusion system market in the near future. For instance, in January 2018, Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) raised around US$ 26.3 Mn as part of a Series D financing round. The raised amount will be used in the development and commercialization of PiCSO Impulse System. Furthermore, the increasing demand for organ transplants is also expected to increase demand for perfusion system and increase its market growth in near future. For instance, according to the data published by National Kidney Foundation as of 2016, around 100,791 people in the U.S. are waiting for kidney transplants.

Perfusion System Market Restraint

High cost of perfusion systems is expected to be the major factor restraining growth of the global perfusion system market. For instance, according to the data published by National Institute for Health and Care Excellence in 2016, cost of the single-use Organ Care System (OCS) Heart Perfusion Set is around US$ 36,904.8, which is very high and not affordable in the developing region such as India, China, and Africa.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.